{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:18:43Z","timestamp":1792703923481,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.euf.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T20:24:16Z","timestamp":1690230256000},"page":"41-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Repeat Transurethral Resection for Non\u2013muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-0712","authenticated-orcid":false,"given":"Takafumi","family":"Yanagisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Bekku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Chlosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2023.07.002_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","article-title":"Role of restaging transurethral resection for t1 non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Naselli","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2023.07.002_b0020","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","article-title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review","volume":"38","author":"Mori","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bju.15383","volume":"128","author":"Sari Motlagh","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/JU.0000000000002444","article-title":"En bloc resection for bladder tumors: an updated systematic review and meta-analysis of its differential effect on safety, recurrence and histopathology","volume":"207","author":"Yanagisawa","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/bju.15920","article-title":"Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators","volume":"131","author":"Del Giudice","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bju.14557","article-title":"Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour","volume":"123","author":"Suarez-Ibarrola","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0045","doi-asserted-by":"crossref","unstructured":"Muilwijk T, Akand M, Raskin Y, et al. Quality control indicators for transurethral resection of bladder tumor: results from an embedded Belgian multicenter prospective registry. Eur Urol Oncol 2023;9:49\u201350.","DOI":"10.1016\/j.euo.2022.11.005"},{"key":"10.1016\/j.euf.2023.07.002_b0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/bju.15760","article-title":"Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?","volume":"131","author":"Yanagisawa","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0055","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2023.07.002_b0060","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1002\/hsr2.178","article-title":"Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives","volume":"3","author":"Lin","year":"2020","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.euf.2023.07.002_b0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.euf.2023.07.002_b0070","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.euf.2023.07.002_b0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2023.07.002_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.euf.2023.07.002_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.euf.2023.07.002_b0090","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org\/handbook."},{"key":"10.1016\/j.euf.2023.07.002_b0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)66442-7","article-title":"Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer","volume":"165","author":"Riedl","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0100","first-page":"141","article-title":"Recurrence rate of superficial bladder carcinoma can be reduced with 5-aminolevulinic acid induced fluorescence diagnosis","volume":"Vol. 4609","author":"Filbeck","year":"2002"},{"key":"10.1016\/j.euf.2023.07.002_b0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(05)64661-7","article-title":"Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy","volume":"168","author":"Kriegmair","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0090-4295(01)01522-9","article-title":"Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?","volume":"59","author":"Schips","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.07.002_b0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.ju.0000070437.14275.e0","article-title":"Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study","volume":"170","author":"Grimm","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000075961","article-title":"Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists","volume":"72","author":"Zurkirchen","year":"2004","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0125","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365590510007793-1","article-title":"Results of second-look resection after primary resection of T1 tumour of the urinary bladder","volume":"39","author":"Jahnson","year":"2005","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euf.2023.07.002_b0135","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0022-5347(05)00689-0","article-title":"Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?","volume":"175","author":"Divrik","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1464-410X.2006.06144.x","article-title":"The value of a second transurethral resection for T1 bladder cancer","volume":"97","author":"Schwaibold","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.07.002_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","article-title":"Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0155","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/end.2007.9866","article-title":"Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach","volume":"21","author":"Schulze","year":"2007","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2023.07.002_b0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.urology.2010.02.067","article-title":"HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer\u2014re-TURBT recurrence rates in a prospective, randomized study","volume":"76","author":"Geavlete","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.07.002_b0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000316073","article-title":"Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?","volume":"85","author":"Yucel","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0970-1591.82833","article-title":"Second transurethral resection in T1G3 bladder tumors\u2014selectively avoidable?","volume":"27","author":"Katumalla","year":"2011","journal-title":"Indian J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0180","doi-asserted-by":"crossref","first-page":"E665","DOI":"10.1016\/j.juro.2011.02.1767","article-title":"Residual T1 disease on repeat transurethral resection for T1 bladder cancer increases risk of progression","volume":"185","author":"Shimko","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0185","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.urology.2011.05.071","article-title":"Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries","volume":"78","author":"Skolarus","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.07.002_b0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/0970-1591.102697","article-title":"An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer","volume":"28","author":"Fujikawa","year":"2012","journal-title":"Indian J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0195","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.urology.2011.08.081","article-title":"Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors\u2014results of a prospective, randomized comparison to the standard approach","volume":"79","author":"Geavlete","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.07.002_b0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000341103","article-title":"Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue","volume":"89","author":"Huang","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00345-012-0975-1","article-title":"Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy","volume":"30","author":"Lodde","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0210","first-page":"269","article-title":"The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer","volume":"6","author":"Vasdev","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.euf.2023.07.002_b0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350512","article-title":"Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?","volume":"91","author":"Suer","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jjco\/hyt016","article-title":"Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era","volume":"43","author":"Takaoka","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","article-title":"Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Gu\u00e9rin","volume":"38","author":"Angulo","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2023.07.002_b0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000353089","article-title":"Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center","volume":"92","author":"Lazica","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0235","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.urolonc.2014.04.005","article-title":"Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology","volume":"32","author":"Neuzillet","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0240","first-page":"1416","article-title":"Repeated transurethral resection for non-muscle invasive bladder cancer","volume":"8","author":"Cao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.euf.2023.07.002_b0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4111\/kju.2015.56.6.429","article-title":"The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: results of a prospective study","volume":"56","author":"Shim","year":"2015","journal-title":"Korean J Urol"},{"issue":"Suppl 4","key":"10.1016\/j.euf.2023.07.002_b0250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bju.13265","article-title":"Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series","volume":"117","author":"Gendy","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.13354","article-title":"The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/grade 3 bladder cancer treated with bacille Calmette-Gu\u00e9rin","volume":"118","author":"Gontero","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0974-7796.163798","article-title":"Results of second transurethral resection for high-grade T1 bladder cancer","volume":"8","author":"Hashine","year":"2016","journal-title":"Urol Ann"},{"key":"10.1016\/j.euf.2023.07.002_b0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12894-016-0126-x","article-title":"Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer","volume":"16","author":"Iida","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4081\/aiua.2016.2.81","article-title":"Prognostic impact of ReTURB in high grade T1 primary bladder cancer","volume":"88","author":"Sanseverino","year":"2016","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.euf.2023.07.002_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.afju.2015.07.004","article-title":"Factors that predict residual tumors in re-TUR patients","volume":"22","author":"T\u00fcrk","year":"2016","journal-title":"Afr J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0280","doi-asserted-by":"crossref","first-page":"603.e1","DOI":"10.1016\/j.urolonc.2017.06.042","article-title":"Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?","volume":"35","author":"Audenet","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0285","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jjco\/hyx030","article-title":"Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer","volume":"47","author":"Fujii","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0290","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4081\/aiua.2017.4.272","article-title":"Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience","volume":"89","author":"Giulianelli","year":"2017","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.euf.2023.07.002_b0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10147-016-1048-z","article-title":"Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study","volume":"22","author":"Kamiya","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/21681805.2017.1303846","article-title":"Second-look resection for primary stage T1 bladder cancer: a population-based study","volume":"51","author":"Patschan","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189354","article-title":"Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer","volume":"12","author":"Tae","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2023.07.002_b0310","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10147-018-1292-5","article-title":"Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer","volume":"23","author":"Baba","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0315","first-page":"287","article-title":"Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?","volume":"71","author":"Dangi","year":"2018","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000490765","article-title":"High-grade T1 on re-transurethral resection after initial high-grade T1 confers worse oncological outcomes: results of a multi-institutional study","volume":"101","author":"Ferro","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.23736\/S0393-2249.18.03042-4","article-title":"Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin: experience of a single center","volume":"70","author":"Hurle","year":"2018","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.euf.2023.07.002_b0330","doi-asserted-by":"crossref","first-page":"9432606","DOI":"10.1155\/2018\/9432606","article-title":"Differences in pathologic results of repeat transurethral resection of bladder tumor (TURBT) according to institution performing the initial TURBT: comparative analyses between referred and nonreferred group","volume":"2018","author":"Yuk","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.euf.2023.07.002_b0335","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.21873\/anticanres.13598","article-title":"Predictive factors for residual cancer in second transurethral resection for non-muscle-invasive bladder cancer","volume":"39","author":"Akitake","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.euf.2023.07.002_b0340","first-page":"152","article-title":"Second transurethral resection of bladder tumor: Is it necessary in all T1 and\/or high-grade tumors?","volume":"16","author":"Ayati","year":"2019","journal-title":"Urol J"},{"key":"10.1016\/j.euf.2023.07.002_b0345","first-page":"252","article-title":"Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer","volume":"72","author":"Czech","year":"2019","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0350","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejso.2018.06.004","article-title":"Narrow band imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer","volume":"45","author":"Giulianelli","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0355","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.euf.2017.10.004","article-title":"Long-term outcomes from re-resection for high-risk non-muscle-invasive bladder cancer: a potential to rationalize use","volume":"5","author":"Gordon","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2023.07.002_b0360","first-page":"105","article-title":"Investigation of clinical outcome and prognosis of 2nd TUR-Bt for T1 high grade bladder cancer","volume":"65","author":"Kato","year":"2019","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.euf.2023.07.002_b0365","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000491642","article-title":"The optimal timing of restaging resection before introduction of bacillus Calmette-Guerin immunotherapy in patients with high-risk non-muscle-invasive bladder cancer","volume":"102","author":"Krajewski","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.07.002_b0370","first-page":"284","article-title":"Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years' experience","volume":"14","author":"Krajewski","year":"2019","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"10.1016\/j.euf.2023.07.002_b0375","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11255-019-02172-8","article-title":"Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience","volume":"51","author":"Tseng","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2023.07.002_b0380","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00345-020-03108-z","article-title":"Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin","volume":"38","author":"Cal\u00f2","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0385","first-page":"e42","article-title":"Repeat transurethral resection is still an essential tool in treating non-muscle invasive bladder cancer: the Western Australian experience","volume":"7","author":"Chang","year":"2020","journal-title":"Bladder (San Franc)"},{"key":"10.1016\/j.euf.2023.07.002_b0390","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s10147-019-01581-0","article-title":"The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial","volume":"25","author":"Eroglu","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0395","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3390\/jcm9103306","article-title":"Restaging transurethral resection of bladder tumours after BCG immunotherapy induction in patients with T1 non-muscle-invasive bladder cancer might not be associated with oncologic benefit","volume":"9","author":"Krajewski","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.euf.2023.07.002_b0400","first-page":"322","article-title":"Second-look TURBT: evaluation of anatomopathological and oncologic results in a single center","volume":"91","author":"Maltagliati","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.euf.2023.07.002_b0405","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jjco\/hyaa041","article-title":"Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis","volume":"50","author":"Matsushita","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0410","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/BLC-200325","article-title":"Deciding when to omit repeat transurethral resection of superficial bladder cancer: do photodynamic diagnostics help?","volume":"6","author":"Sailer","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euf.2023.07.002_b0415","first-page":"440","article-title":"Value of separate tumor base biopsy in transurethral resection of bladder tumors","volume":"73","author":"Sionov","year":"2020","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0420","doi-asserted-by":"crossref","first-page":"77.e1","DOI":"10.1016\/j.urolonc.2019.08.010","article-title":"Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?","volume":"38","author":"Soria","year":"2020","journal-title":"Urol Oncol"},{"issue":"15_suppl","key":"10.1016\/j.euf.2023.07.002_b0425","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e17018","article-title":"Predicting residual tumor for T1 high-grade bladder urothelial carcinoma before second transurethral resection specimens","volume":"38","author":"Takeuchi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0430","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/iju.14372","article-title":"Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer","volume":"27","author":"Taoka","year":"2020","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0435","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21681805.2021.1917652","article-title":"The use of reTURB in T1 bladder cancer: a Norwegian population-based study","volume":"55","author":"Blindheim","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0440","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/21681805.2021.1892179","article-title":"A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer","volume":"55","author":"Bobjer","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0445","doi-asserted-by":"crossref","first-page":"437.e11","DOI":"10.1016\/j.urolonc.2021.02.009","article-title":"Can repeat biopsy be skipped after initial complete resection of T1 bladder cancer? The role of a novel urinary mRNA biomarker","volume":"39","author":"Elsawy","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0450","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.euf.2020.12.003","article-title":"Holmium laser en-bloc resection versus conventional transurethral resection of bladder tumors for treatment of non-muscle-invasive bladder cancer: a randomized clinical trial","volume":"7","author":"Hashem","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2023.07.002_b0455","first-page":"145","article-title":"En-bloc resection of urinary bladder tumour\u2014a prospective controlled multicentre observational study","volume":"16","author":"Poletajew","year":"2021","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"10.1016\/j.euf.2023.07.002_b0460","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13924","article-title":"Ta grade 3\/high grade non-invasive bladder cancer: Should we perform a second TUR?","volume":"75","author":"Tinay","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.euf.2023.07.002_b0465","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1089\/end.2021.0008","article-title":"Clinical outcomes of reresection in patients with high-risk nonmuscle-invasive bladder cancer treated with en bloc transurethral resection: a retrospective study with a 1-year follow-up","volume":"35","author":"Xu","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2023.07.002_b0470","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.acuro.2021.07.002","article-title":"The probability of residual tumor detection in the second transurethral resection of pT1 urothelial bladder cancer according to the risk factors","volume":"46","author":"Culpan","year":"2022","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2023.07.002_b0475","article-title":"Risk stratification for the rate and location of residual bladder tumor for the decision of re-transurethral resection of bladder tumor","volume":"12","author":"Fan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0480","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/iju.14761","article-title":"Outcomes of bacillus Calmette-Gu\u00e9rin therapy without a maintenance schedule for high-risk non-muscle-invasive bladder cancer in the second transurethral resection era","volume":"29","author":"Kikuchi","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0485","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/iju.14854","article-title":"Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)","volume":"29","author":"Kobayashi","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.102838","article-title":"Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer","volume":"38","author":"Taoka","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.euf.2023.07.002_b0495","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/bju.15622","article-title":"Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study","volume":"129","author":"Wettstein","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0500","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1245\/s10434-023-13227-7","article-title":"En bloc resection versus conventional TURBT for T1HG bladder cancer: a propensity score-matched analysis","volume":"30","author":"Yanagisawa","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0505","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2023.07.002_b0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1464-410X.2009.09119.x","article-title":"Narrow-band imaging cystoscopy to evaluate bladder tumours\u2014individual surgeon variability","volume":"106","author":"Herr","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0515","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1464-410X.2008.08244.x","article-title":"Two centuries of cystoscopy: the development of imaging, instrumentation and synergistic technologies","volume":"103","author":"Samplaski","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0520","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","article-title":"Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from Scotland's Quality Performance Indicators Programme","volume":"78","author":"Mariappan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0525","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12894-020-00599-1","article-title":"Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0530","doi-asserted-by":"crossref","unstructured":"Zhou M, Yang B, Zhou S, et al. Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis. J Cancer Res Clin Oncol. In press. https:\/\/doi.org\/10.1007\/s00432-022-04564-3.","DOI":"10.1007\/s00432-022-04564-3"},{"key":"10.1016\/j.euf.2023.07.002_b0535","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0540","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/bju.15944","article-title":"Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis","volume":"131","author":"Yanagisawa","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0545","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.07.002_b0550","doi-asserted-by":"crossref","first-page":"40.e17","DOI":"10.1016\/j.urolonc.2013.04.009","article-title":"Presence of detrusor muscle in bladder tumor specimens\u2013predictors and effect on outcome as a measure of resection quality","volume":"32","author":"Shoshany","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2023.07.002_b0555","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2011.10571.x","volume":"109","author":"Mariappan","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.07.002_b0560","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1016\/j.juro.2018.02.2278","article-title":"MP71-14 Frequency of low grade T1 bladder cancer has decreased but continues to vary by institution","volume":"199","author":"Jordan","year":"2018","journal-title":"J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:56:20Z","timestamp":1762498580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456923001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405456923001736"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2023.07.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeat Transurethral Resection for Non\u2013muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}